Collagen Solutions plc Stock price

Equities

COS

GB00B94T6Y14

Delayed London S.E. 11:35:02 2020-11-16 am EST 5-day change 1st Jan Change
6.625 GBX -.--% Intraday chart for Collagen Solutions plc -.--% +94.85%
Sales 2018 3.5M 4.42M Sales 2019 4.15M 5.24M Capitalization 12.17M 15.35M
Net income 2018 -2M -2.52M Net income 2019 -1M -1.26M EV / Sales 2018 2.32 x
Net cash position 2018 2.1M 2.65M Net Debt 2019 830K 1.05M EV / Sales 2019 3.13 x
P/E ratio 2018
-3.98 x
P/E ratio 2019
-7.3 x
Employees -
Yield 2018 *
-
Yield 2019
-
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 53 15-11-17
Chief Tech/Sci/R&D Officer - -
Sales & Marketing - -
Members of the board TitleAgeSince
Corporate Officer/Principal 64 18-04-15
Chief Executive Officer 53 15-11-17
Director/Board Member - 20-11-16
More insiders
Collagen Solutions plc is a holding company. The Company is engaged in the business of supply, development and manufacture of medical grade collagen components and biomaterials. The Company's products and services are utilized in the research, diagnostics, medical devices and regenerative medicine markets. The Company's main products include Collagen and tissue biomaterials. The Company's product range includes raw tissue supply, including pericardium, which is used in heart valves and dural patches, various strengths of soluble and acid soluble collagen, acid swollen gels, freeze-dried powders, collagen sheets and fibrous collagen. The Company also manufactures Excellagen, a collagen gel used in wound care and cell therapy fields. Its services include product development and contract manufacturing. It offers a range of bovine spongiform encephalopathy (BSE)-free bovine biomaterials to meet customer specifications, including bone, cartilage and tendon, and veins and blood vessels.
Sector
-
More about the company
  1. Stock
  2. Equities
  3. Stock Collagen Solutions plc - London S.E.